AMIKACIN Sulphate Injection IP 250MG – MKC 250 Injection

MKC 250 Injection
Composition:- AMIKACIN 250 INJ

MKC 250 Injection – Amikacin Sulphate Injection IP 250MG is a potent aminoglycoside antibiotic indicated for the treatment of serious infections caused by resistant Gram-negative bacteria, and is selectively effective against some Gram-positive pathogens.
Amikacin acts by binding to the 30S ribosomal subunit, disrupting bacterial protein synthesis and resulting in bactericidal action. This injectable antibiotic is preferred in clinical settings requiring rapid, reliable control over systemic and localized infections caused by resistant strains.

Key Points of AMIKACIN Sulphate Injection IP 250MG – MKC 250 Injection
• Potent Bactericidal Activity: Highly effective against drug-resistant Gram-negative organisms like Pseudomonas aeruginosa, E. coli, and Klebsiella spp.
• Trusted in Critical Infections: Indicated for managing severe infections, including sepsis, nosocomial pneumonia, and osteomyelitis.
• Fast Systemic Action: Delivers rapid therapeutic concentrations through IV/IM routes—ideal in emergency or intensive care scenarios.
• Useful in Drug-Resistant Scenarios: A key option when gentamicin or other aminoglycosides prove ineffective.

Can be Prescribed by:
• Pulmonologists
• Urologists
• General Surgeons
• Neonatologists & Pediatricians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.